Voltarol 25 mg Норвегия - норвежский - Statens legemiddelverk

voltarol 25 mg

glaxosmithkline consumer aps - diklofenakkalium - kapsel, myk - 25 mg

Dimethyl fumarate Glenmark 240 mg Норвегия - норвежский - Statens legemiddelverk

dimethyl fumarate glenmark 240 mg

glenmark arzneimittel gmbh - dimetylfumarat - enterokapsel, hard - 240 mg

Dimethyl fumarate Glenmark 120 mg Норвегия - норвежский - Statens legemiddelverk

dimethyl fumarate glenmark 120 mg

glenmark arzneimittel gmbh - dimetylfumarat - enterokapsel, hard - 120 mg

Dimethyl fumarate Neuraxpharm Европейский союз - норвежский - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Mylan Европейский союз - норвежский - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Европейский союз - норвежский - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Европейский союз - норвежский - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressive - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord Европейский союз - норвежский - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressive - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).